Literature DB >> 8011295

Mechanisms of transplantation tolerance.

B Charlton1, H Auchincloss, C G Fathman.   

Abstract

Transplantation tolerance, the long-term acceptance of grafted tissue in the absence of continuous immunosuppression, remains an elusive goal in humans, but it has been achieved in animal models using numerous approaches. The mechanisms behind graft acceptance vary according to the means used to create the state of acceptance. Several major mechanisms can now be recognized. While thymic deletion of T cells appears to be a mainstay of self-tolerance, its role in transplantation tolerance now seems to be less significant. In contrast, extrathymic mechanisms of transplantation tolerance seem to be major factors in long-term graft acceptance. If donor antigens are presented in a nonimmunogenic manner on the graft, e.g. due to modification of graft tissue by culture, peripheral T cells of the recipient may ignore the graft. Alternatively, nonstimulatory presentation of donor antigens on graft tissue can induce a state of unresponsiveness in recipient T cells, i.e. anergy, rather than activating them to destroy the graft. Suppression mechanisms also operate to control graft rejection and may be specific or nonspecific in nature. Specific suppression mechanisms might act in an idiotype or antigen-specific fashion, and evidence is accumulating that this may be mediated through the elaboration of cytokines. Donor antigen-specific T cells may be activated to produce "protective" cytokines which then regulate the generation of destructive T cells. Future therapies will be aimed at affecting graft acceptance through these peripheral mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011295     DOI: 10.1146/annurev.iy.12.040194.003423

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  12 in total

1.  Requirement for natural killer T (NKT) cells in the induction of allograft tolerance.

Authors:  K I Seino; K Fukao; K Muramoto; K Yanagisawa; Y Takada; S Kakuta; Y Iwakura; L Van Kaer; K Takeda; T Nakayama; M Taniguchi; H Bashuda; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

Review 2.  Paradigm changes in organ transplantation: a journey toward selflessness?

Authors:  K F Schaffner
Journal:  Theor Med Bioeth       Date:  1998-09

3.  Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection.

Authors:  J A Shizuru; I L Weissman; R Kernoff; M Masek; Y C Scheffold
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

4.  Hematopoietic cell transplantation for tolerance induction.

Authors:  N S Kenyon; C Ricordi
Journal:  Cytotechnology       Date:  1998-01       Impact factor: 2.058

5.  Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells.

Authors:  M Alterio de Goss; R Holtappels; H P Steffens; J Podlech; P Angele; L Dreher; D Thomas; M J Reddehase
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 6.  Transplantation tolerance: fooling mother nature.

Authors:  M Suthanthiran
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

7.  Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A.

Authors:  G L Evans; R A Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 8.  Transgenesis in rats: technical aspects and models.

Authors:  B Charreau; L Tesson; J P Soulillou; C Pourcel; I Anegon
Journal:  Transgenic Res       Date:  1996-07       Impact factor: 2.788

9.  Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10.

Authors:  Y A Nedialkov; V L Motin; R R Brubaker
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

10.  Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.

Authors:  Kenneth D Bishop; John E Harris; John P Mordes; Dale L Greiner; Aldo A Rossini; Michael P Czech; Nancy E Phillips
Journal:  Cell Immunol       Date:  2009-02-23       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.